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I. Introduction 
Doxorubicin (AdriamycinR) and the related com- 
pound daunorubicin (Daunomycin) are antibiotics of 
the anthracycline group [l] with cytotoxic and anti- 
mitotic activity [2]. Their clinical uses in the treat- 
ment of acute leukemia and solid tumors have been 
reviewed [3-51. Their biological activity is linked to 
the formation of an intercalative complex with DNA 
[6-S] with concomitant i~libition of both RNA and 
DNA synthesis (9,101. Doxorubicin is also known to 
interact with phospholipids [ 11 ,I 2) and with sulphated 
mucopolysaccharides [131. On the other hand, 
Daunorubicin has been shown to bind to non-histone 
protein from rat liver [ 141 and, due to the presence 
of planar aromatic rings in its quinone moiety, to 
interact strongly with itself [ 151, forming mostly 
dimers and tetramers, as already shown for many 
similar compounds like actinomycin, proflavin, 
purines or acridine orange. This self-association, in 
turn, should affect the acid dissociation constants of 
the two groups ionizable at or near physioiogic~ pH, 
i.e., the 3’-NHz group in the sugar moiety and the 
11 -OH group in the quinone ring. This could explain 
why literature data on the amino group pK values 
varyfrom7.2-8.99 [1,16,17] andfrompK9.54-10.1 
for the phenolic -OH [ 16,181. These pK’ values have 
been determined by potentiometric (amino group) as 
well as by spectrophotometric and fluorimetric 
(‘phenolic -OH) titrations and, more recently, on the 
basis of partition coefficients in chloroform-l - 
pentanol [16]. 
In this report, we have attempted to measure 
protolytic equilibria of doxorubicin indirectly, by 
equilibrium isoelectric focusing, by p1 and Apl value 
determinations, and directly, by using ‘electrophoretic 
titration curves’. This last technique, described 
[ 19,201, has been successfully applied to the study of 
macromolecule-ligands [21] and macromolecule- 
macromolecule interactions [22]. 
2. Materials and methods 
Uniabelled and [14C]doxorubicin (spec. act, 
24.5 #&‘mg) were prepared as hydrochloride deriva- 
tives at the Farmitalia Laboratories. Ampholine 
(pH 3.5-10) was from LKB Produkter AB, Bromma. 
Urea (ultrapure), acrylamide and NJ’-methylene 
bisacrylamide were from Bio Rad Labs, Richmond, CA. 
Equilibrium isoelectric focusing [23], the two 
dimensional isoelectric focusing-electrophoresis 
technique [20] and pH measurements [24] were 
performed as described. In 8 M urea gels, pH measure- 
ments were made by eluting the gel slices in 300 ~1 
10 mM KCl-8 M urea solution and then by sub- 
tracting from the pH readings a correction factor of 
0.42 pH units [25]. When focusing [i4C]doxorubicin, 
2 mm gel segments were cut along the separation 
track, transferred to counting vials, and eluted over- 
night in 0.5 ml 10 mM KCl. After additon of 8 ml 
Packard Insta Gel (Downers Grove, IL) the samples 
were counted in a Beckman LS 3100 /3-spectrometer. 
pH measurements were made on 2 mm gel strips cut 
alongside the gel strips used for radioisotope counting. 
The spectrophotometric titration curves were 
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performed with a Coleman Perkin Elmer 575 in 
0.04% ampholine buffers covering the pH 5-l 1 
range. This procedure was found to give more 
reproducible results than titrations in standard buffers. 
3. Results and discussion 
Figure 1 shows the [ 14C] doxorubicin profile in 
isoelectric focusing as a function of progressive 
dilution (from 6-0.2 pg/ml). The insert shows 
focused unlabelled doxorubicin at higher concentra- 
tions (from 100 pg/ml to 7 mg/ml). It can be seen 
that doxorubicin is indeed an amphoteric molecule, 
as predictable from its structure, and is also a ‘good 
carrier ampholyte’ [26] since it focuses very sharply 
(PI - pK difference <l .O). Moreover, the isoelectric 
point (PI) is seen to be a function of the concentra- 
tion, and progressively decreases with increasing 
dilutions, from ~19.33 (>2 mg/ml) down to pI 8.76 
(Gl pg/ml). These p1 variations must reflect pK 
alterations of ionizable groups in doxorubicin brought 
about by self-association. 
In fig.2 we have plotted p1 values as a function of 
concentration. On the diluted side, p1 constancy 
(PI 8.76) is reached in -2 PM solutions, while on the 
concentrated side a p1 plateau (p1 9.33) is attained in 
-2 mM solutions. This means that these concentra- 
tions must correspond to fully disaggregated (mono- 
meric, -MM solutions) and fully aggregated (tetra- 
merit or n-merit species, -mM solutions), respectively. 
When these experiments are repeated in 8 M urea, the 
monomeric pI value is kept at much higher concentra- 
tions, <lo0 pg/ml (-0.2 mM solutions) indicating 
that urea effectively disaggregates these complexes. 
At higher concentrations, the p1 rises but not above 
I 
5 
slice number 
Fig.1. Isoelectric focusing of [Wldoxorubicin in a 7% acrylamide gel, containing 2% Ampholine (pH 3.5-10). The sample was 
applied in pockets precast in the gel at the anodic side. After focusing, 2 mm gel segments were cut along the separation track 
and counted as in section 2. Solid lines refer to the 3000 cpm full scale, while broken lines refer to the 300 cpm scale. (= - n ) pH 
gradient. Insert: focusing of unlabelled doxorubicin at >lOO pg/ml. Loads: (1) 0.1 mg/ml; (2) 0.2 mg/ml; (3) 0.5 mg/ml; (4) 
1 mg/ml; (5) 2.5 mg/ml; (6) 5 mg/ml; (7) 7.5 mg/ml. Of each stock solution, 20 ~1 were loaded in the gel. Notice the bow-shaped 
profile, indicating a decreasing of pI with progressive sample dilution. The black strip is the electrode filter paper. 
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Fig.2. Variation of the pl of doxorubicin as a function of its concentration in solution upon focusing in the presence and in the 
absence of urea. The plateau in the diluted side indicates the presence of (mostly) monomeric species while the plateau in the con- 
centrated side indicates the attainment of fully aggregated forms. Notice that in 8 M urea the monomeric state is kept at lOO-fold 
higher concentration (-0.2 mM) than in the absence of urea. The insert (same samples and loads as in fig.1) shows the focusing of 
u&belled doxorubicin in an 8 M urea gel. Notice the much gentler arching of the samples, as compared to fig.1, indicating the 
attainment of an aggregation state of lower degree. 
a limiting pI 9.2, indicating that the aggregate forms 
do not reach the polymeric order attainable in 
absence of urea. This is in agreement with our studies 
with dyes [27], where full disaggregation at high 
concentrations could only be achieved by combining 
8 M urea with high temperatures (55°C) and with the 
data in [ 151, where the circular dicroic spectrum of 
concentrated daunorubicin was shown to be shifted 
at high temperatures toward the spectrum of diluted 
solutions. 
These data do not allow us to calculate any of the 
two pK values of doxorubicin. However, since the p1 
must be equidistant from the two pK values, one of 
the pK values can be easily derived from the well 
known equation p1 = (pKr + pKz)/2 provided the 
other pK is measured by an independent method. 
Since the sugar amino group is several atoms removed 
from the aromatic chromophore, its degree of proto- 
nation should not affect the electronic spectrum of 
doxorubicin, therefore the spectrophotometric 
titration of the phenolic group should give an accurate 
estimate of its pK. Figure 3 reports the pK value of 
the phenolic group and its variation upon dilution. 
Since in -2 mM solutions the pK_0, 10.15, a pK_,,: 
8.5 1 is derived. In very dilute solutions (-2 PM), pK_0, 
9.60, from which a ~K_,J,: 7.92 can be cal- 
culated. Thus, monomeric doxorubicin should have a 
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Fig.3. Spectrophotometric titration curve of the phenolic 
-OH. Titrations were performed in 0.04% Ampholine 
(pH 5-l 1) with a Coleman Perkin Elmer 575 spectrophotom- 
eter. At each concentration analyzed, the pK of the phenolic 
-OH has been graphically derived as the inflection point of 
the titration curve obtained by plotting the A,,, values as a 
function of pH. 
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PK_~~ 9.60 and PK+~; 7.92. While the phenolic 
group pri- is in excellent agreement with [16], the 
ply_,,; 7.2 t 0.05 reported therein seems to be 
much too low in comparison with our pK value and 
other literature data [13-151. If this low value were 
correct, we should find p1 8.37 for dilute doxorubicin 
solutions, while we cannot reach a pI<8.76 even in 
0.3 ,uM solutions, i.e., with dilutions lower than [ 151 
or comparable to [ 161 literature values. 
In fig.4, we have attempted to titrate directly the 
amino group by the recently described technique of 
‘electrophoretic titration curves’ [20-231. The shape 
Fig.4. Direct ‘electrophoretic titration curve’ of doxorubicin. 
Gel slab (2 mm thick): 7% acrylamide, 2% Ampholine 
(pH 3.5-lo), 5 mM Asp, 5 mM Glu, 5 mM Lys and 8 M urea. 
First dimension: 90 min run in the LKB Multiphor chamber 
by delivering 10 W with an LKB constant wattage power 
supply. Coolant temperature: 10°C. Second dimension: 
15 min run by delivering 600 V (constant) across 13 cm 
electrode distance. The two arrows and positive and negative 
symbols represent he direction and polarity of isoelectric 
focusing (IEF) and electrophoresis (El.). The arrowhead 
indicates the sample application zone (i.e. the zero-mobility 
or isoelectric plane). The two black strips are the electrolyte 
filter paper strips used in the second dimension. The pH 
gradient shown is already corrected for the presence of 8 M 
urea. The solution loaded here is doxorubicin at 0.5 mg/ml 
but the pK calculations have been performed on an identical 
run with 0.1 mg/mI (which did not show any deviation from 
ideal behavior), not shown because too faint for a good 
photographic reproduction. 
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of the doxorubicin curve clearly shows that, as the 
molecule moves against the stationary pH gradient, it 
is continuously titrated over pH 3-10. Above the iso- 
electric point (the pH of crossing over the application 
trench) it behaves in fact as an anion, changing to 
the bright violet color of the phenolate ion. Below 
the PI, it behaves as a cation, reverting to its typical 
orange color. As the amino group is progressively 
protonated, the cationic mobility increases until, at 
pH “7, constant mobility is achieved, indicating that 
the amino group is fully charged (or very nearly so, 
since at this point small charge changes can go 
undetected). At pH <7 all the way down to the end 
of the titrations curve, the doxorubicin band is com- 
pletely flat, and exactly parallel to the application 
trench, indicating that no charge changes take place 
in the molecule. This too indicates that the app. 
pK 7.2 reported [ 161 cannot hold true, otherwise 
constant mobility would have been achieved at pH “6, 
rather than pH -7. The apparent mobility increase at 
the acidic end of the titration curve is an artefact, 
probably due to an edge effect, or perhaps to inter- 
action with carrier ampholytes, since this phenome- 
non is greatly enhanced when the titration curve is 
run in the absence of urea. 
In order to obtain exact plil values from the titra- 
tion curve: we have derived a mathematics equation 
describing it. By assuming that: 
1. The total electrophoretic mobility (121;) of a mono- 
mono- valent amphoteric moIecule is proportional 
to its degree of ionization; 
2. The viscosity and degree of polymerization of 
acrylamide are constant along the gel length; 
3. The conductivity along each focused Ampholine 
species is constant; 
4. The molecule does not change size or shape along 
the pH 3-10 gradient; 
we have derived the following equation (full mathe- 
matical treatment will be given elsewhere): 
HOP& - PH _ 1 OPH - pk’, 
Mt = /l ---- 
1 t 1 ()PKc - PH t 1OPH - PKa 
0) 
where K, and K, are the dissociation constants of 
cations and anions, respectively, and h is a propor- 
tionality coefficient. In our case, since accurate 
mobility ~lleasurenlellts can only be made in the 
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‘cationic’ portion of the titration curve, pK, will be 
derived by measuring the pH (pH%) corresponding to 
% mobility in the cathodic direction, corrected by a 
correction factor accounting for the influence of the 
degree of ionization of the phenolate ion on the 
value of % mobility. Thus, by substituting in eq. (1) 
the value pK, = 2 pI - pK, and the value pH $5 
corresponding to s/z mobility, we obtain: 
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